BIOGEN INC. Proceeds from (Payments for) Other Financing Activities
BIOGEN INC. (BIIB) reported Proceeds from (Payments for) Other Financing Activities of $11.30 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2026-04-29
- BIOGEN INC. proceeds from (payments for) other financing activities for the quarter ending 2026-03-31 was $11.30M, a 769.23% increase year-over-year.
- BIOGEN INC. proceeds from (payments for) other financing activities for the quarter ending 2025-12-31 was -$1.30M, a 129.55% decline year-over-year.
- BIOGEN INC. proceeds from (payments for) other financing activities for the quarter ending 2025-09-30 was $6.20M.
- BIOGEN INC. proceeds from (payments for) other financing activities for the quarter ending 2025-06-30 was -$1.20M.
- BIOGEN INC. proceeds from (payments for) other financing activities for fiscal 2025 was $5.00M.
- BIOGEN INC. proceeds from (payments for) other financing activities for fiscal 2024 was -$2.20M.
- BIOGEN INC. proceeds from (payments for) other financing activities for fiscal 2023 was -$6.00M.
- BIOGEN INC. proceeds from (payments for) other financing activities for fiscal 2022 was -$5.60M.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 3 month as first filed | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 6 month as first filed | Proceeds from (Payments for) Other Financing Activities 9 month | Proceeds from (Payments for) Other Financing Activities 9 month as first filed | Proceeds from (Payments for) Other Financing Activities 12 month | Proceeds from (Payments for) Other Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $11.30M 10-Q · filed 2026-04-29 | $10.00M derived: sum of 2 quarters · filed 2026-04-29 | $16.20M derived: sum of 3 quarters · filed 2026-04-29 | $15.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $4.90M derived: sum of 2 quarters · filed 2026-02-06 | $3.70M derived: sum of 3 quarters · filed 2026-02-06 | $5.00M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.00M derived: sum of 2 quarters · filed 2025-10-30 | $6.30M 10-Q · filed 2025-10-30 | $10.70M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $100.00K 10-Q · filed 2025-07-31 | $4.50M derived: sum of 3 quarters · filed 2026-04-29 | -$8.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $1.30M 10-Q · filed 2026-04-29 | $5.70M derived: sum of 2 quarters · filed 2026-04-29 | -$6.90M derived: sum of 3 quarters · filed 2026-04-29 | -$8.20M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$8.20M derived: sum of 2 quarters · filed 2026-02-06 | -$9.50M derived: sum of 3 quarters · filed 2026-02-06 | -$2.20M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | -$12.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$13.90M derived: sum of 2 quarters · filed 2025-10-30 | -$6.60M 10-Q · filed 2025-10-30 | -$14.50M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $6.00M 10-Q · filed 2025-07-31 | -$1.90M derived: sum of 3 quarters · filed 2026-02-06 | $300.00K derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $7.30M 10-Q · filed 2025-05-01 | -$600.00K derived: sum of 2 quarters · filed 2026-02-06 | $1.60M derived: sum of 3 quarters · filed 2026-02-06 | -$15.20M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | -$7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$5.70M derived: sum of 2 quarters · filed 2026-02-06 | -$22.50M derived: sum of 3 quarters · filed 2026-02-06 | -$6.00M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$14.60M derived: sum of 2 quarters · filed 2024-10-30 | $1.90M 10-Q · filed 2024-10-30 | -$9.60M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$16.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$300.00K 10-Q · filed 2024-08-01 | -$11.80M derived: sum of 3 quarters · filed 2025-02-12 | -$17.30M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $16.50M 10-Q · filed 2024-04-24 | $5.00M derived: sum of 2 quarters · filed 2025-02-12 | -$500.00K derived: sum of 3 quarters · filed 2025-02-12 | $6.80M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$17.00M derived: sum of 2 quarters · filed 2025-02-12 | -$9.70M derived: sum of 3 quarters · filed 2025-02-12 | -$5.60M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | -$5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.80M derived: sum of 2 quarters · filed 2023-11-08 | $5.90M 10-Q · filed 2023-11-08 | $7.70M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $7.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $11.40M 10-Q · filed 2023-07-25 | $13.20M derived: sum of 3 quarters · filed 2024-02-14 | $10.80M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $4.10M 10-Q · filed 2023-04-25 | $5.90M derived: sum of 2 quarters · filed 2024-02-14 | $3.50M derived: sum of 3 quarters · filed 2024-02-14 | -$28.40M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$600.00K derived: sum of 2 quarters · filed 2024-02-14 | -$32.50M derived: sum of 3 quarters · filed 2024-02-14 | -$21.10M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | -$2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | -$34.30M derived: sum of 2 quarters · filed 2022-10-25 | -$22.90M 10-Q · filed 2022-10-25 | -$31.20M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | -$31.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | -$20.50M 10-Q · filed 2022-07-20 | -$28.80M derived: sum of 3 quarters · filed 2023-02-15 | -$24.90M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $11.40M 10-Q · filed 2022-05-03 | $3.10M derived: sum of 2 quarters · filed 2023-02-15 | $7.00M derived: sum of 3 quarters · filed 2023-02-15 | $21.50M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$4.40M derived: sum of 2 quarters · filed 2023-02-15 | $10.10M derived: sum of 3 quarters · filed 2023-02-15 | $14.60M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $18.40M derived: sum of 2 quarters · filed 2021-10-20 | $22.90M 10-Q · filed 2021-10-20 | -$17.30M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $14.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $19.00M 10-Q · filed 2021-07-22 | -$21.20M derived: sum of 3 quarters · filed 2022-02-03 | $1.00M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $4.50M 10-Q · filed 2021-04-22 | -$35.70M derived: sum of 2 quarters · filed 2022-02-03 | -$13.50M derived: sum of 3 quarters · filed 2022-02-03 | -$600.00K derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | -$40.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | -$18.00M derived: sum of 2 quarters · filed 2022-02-03 | -$5.10M derived: sum of 3 quarters · filed 2022-02-03 | $3.60M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $22.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | $35.10M derived: sum of 2 quarters · filed 2020-10-21 | $43.80M 10-Q · filed 2020-10-21 | $10.40M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | $12.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $21.60M 10-Q · filed 2020-07-22 | -$11.80M derived: sum of 3 quarters · filed 2021-02-03 | $6.90M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $8.70M 10-Q · filed 2020-04-23 | -$24.70M derived: sum of 2 quarters · filed 2021-02-03 | -$6.00M derived: sum of 3 quarters · filed 2021-02-03 | -$15.50M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | -$33.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | -$14.70M derived: sum of 2 quarters · filed 2021-02-03 | -$24.20M derived: sum of 3 quarters · filed 2021-02-03 | -$21.60M 10-K · filed 2021-02-03 | -$19.50M 10-K · filed 2019-02-06 | |||
| 2018-09-30 | $18.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $9.20M derived: sum of 2 quarters · filed 2019-10-22 | $11.80M 10-Q · filed 2019-10-22 | -$12.20M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | -$9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$6.90M 10-Q · filed 2019-07-24 | -$3.70M 10-Q · filed 2018-07-24 | -$30.90M derived: sum of 3 quarters · filed 2020-02-06 | -$54.30M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2018-03-31 | $2.60M 10-Q · filed 2019-04-24 | -$21.40M derived: sum of 2 quarters · filed 2020-02-06 | -$44.80M derived: sum of 3 quarters · filed 2020-02-06 | -$21.70M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | -$24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | -$47.40M derived: sum of 2 quarters · filed 2020-02-06 | -$24.30M derived: sum of 3 quarters · filed 2020-02-06 | -$13.90M 10-K · filed 2020-02-06 | -$8.60M 10-K · filed 2018-02-01 | |||
| 2017-09-30 | -$23.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$300.00K derived: sum of 2 quarters · filed 2018-10-23 | $10.10M 10-Q · filed 2018-10-23 | -$30.60M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $23.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | $33.50M 10-Q · filed 2018-07-24 | -$7.20M derived: sum of 3 quarters · filed 2019-02-06 | $29.60M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | $10.40M 10-Q · filed 2018-04-24 | -$30.30M derived: sum of 2 quarters · filed 2019-02-06 | $6.50M derived: sum of 3 quarters · filed 2019-02-06 | -$17.00M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | -$40.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$3.90M derived: sum of 2 quarters · filed 2019-02-06 | -$27.40M derived: sum of 3 quarters · filed 2019-02-06 | -$2.80M 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | $36.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | $13.30M derived: sum of 2 quarters · filed 2017-10-24 | $37.90M 10-Q · filed 2017-10-24 | $94.80M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | -$23.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $1.10M 10-Q · filed 2017-07-25 | $58.00M derived: sum of 3 quarters · filed 2018-02-01 | -$19.10M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $24.60M 10-Q · filed 2017-04-25 | $81.50M derived: sum of 2 quarters · filed 2018-02-01 | $4.40M derived: sum of 3 quarters · filed 2018-02-01 | $30.70M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $56.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$20.20M derived: sum of 2 quarters · filed 2018-02-01 | $6.10M derived: sum of 3 quarters · filed 2018-02-01 | -$5.20M 10-K · filed 2018-02-01 | -$74.40M 10-K · filed 2016-02-03 | |||
| 2015-09-30 | -$77.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | -$50.80M derived: sum of 2 quarters · filed 2016-10-26 | -$62.10M 10-Q · filed 2016-10-26 | -$62.15M 10-Q · filed 2015-10-21 | -$43.96M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | $26.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $15.00M 10-Q · filed 2016-07-21 | $14.99M 10-Q · filed 2015-07-24 | $33.14M derived: sum of 3 quarters · filed 2017-02-02 | $5.80M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | -$11.30M 10-Q · filed 2016-04-21 | -$11.29M 10-Q · filed 2015-04-24 | $6.84M derived: sum of 2 quarters · filed 2017-02-02 | -$20.50M derived: sum of 3 quarters · filed 2017-02-02 | -$21.56M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $18.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$9.20M derived: sum of 2 quarters · filed 2017-02-02 | -$10.26M derived: sum of 3 quarters · filed 2017-02-02 | $2.80M 10-K · filed 2017-02-02 | -$17.68M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | -$27.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | -$28.39M derived: sum of 2 quarters · filed 2015-10-21 | -$15.34M 10-Q · filed 2015-10-21 | -$20.11M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | $12.00M 10-Q · filed 2015-07-24 | $7.23M derived: sum of 3 quarters · filed 2016-02-03 | $16.04M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $13.06M 10-Q · filed 2015-04-24 | $8.29M derived: sum of 2 quarters · filed 2016-02-03 | $17.09M derived: sum of 3 quarters · filed 2016-02-03 | $15.57M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | -$4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $4.04M derived: sum of 2 quarters · filed 2016-02-03 | $2.52M derived: sum of 3 quarters · filed 2016-02-03 | -$4.10M 10-K · filed 2016-02-03 | -$4.12M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $8.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $7.29M derived: sum of 2 quarters · filed 2014-10-22 | $670.00K 10-Q · filed 2014-10-22 | $68.57M 10-Q · filed 2013-10-28 | -$54.84M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2013-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | -$8.14M 10-Q · filed 2014-07-23 | $45.17M 10-Q · filed 2013-07-25 | -$63.64M derived: sum of 3 quarters · filed 2015-02-04 | -$53.87M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2013-03-31 | -$6.62M 10-Q · filed 2014-04-23 | $30.78M 10-Q · filed 2013-04-25 | -$62.12M derived: sum of 2 quarters · filed 2015-02-04 | -$52.35M derived: sum of 3 quarters · filed 2015-02-04 | -$42.01M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2012-12-31 | -$55.51M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | -$45.73M derived: sum of 2 quarters · filed 2015-02-04 | -$35.39M derived: sum of 3 quarters · filed 2015-02-04 | -$12.57M 10-K · filed 2015-02-04 | -$7.34M 10-K · filed 2013-02-05 | |||
| 2012-09-30 | $9.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $20.11M derived: sum of 2 quarters · filed 2013-10-28 | $42.94M 10-Q · filed 2013-10-28 | $105.48M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $10.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $33.17M 10-Q · filed 2013-07-25 | $95.71M derived: sum of 3 quarters · filed 2014-02-06 | -$17.00M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $22.83M 10-Q · filed 2013-04-25 | $85.37M derived: sum of 2 quarters · filed 2014-02-06 | -$27.34M derived: sum of 3 quarters · filed 2014-02-06 | -$8.87M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $62.54M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$50.17M derived: sum of 2 quarters · filed 2014-02-06 | -$31.70M derived: sum of 3 quarters · filed 2014-02-06 | -$27.40M 10-K · filed 2014-02-06 | -$338.00K 10-K · filed 2013-02-05 | |||
| 2011-09-30 | -$112.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | -$94.24M derived: sum of 2 quarters · filed 2012-10-25 | -$89.94M 10-Q · filed 2012-10-25 | |||||
| 2011-06-30 | $18.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | $22.77M 10-Q · filed 2012-07-24 | ||||||
| 2011-03-31 | $4.30M 10-Q · filed 2012-05-01 | |||||||
| 2010-12-31 | $10.61M 10-K · filed 2013-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |